Source:http://linkedlifedata.com/resource/pubmed/id/16884941
| Subject | Predicate | Object | Context |
|---|---|---|---|
| pubmed-article:16884941 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16884941 | lifeskim:mentions | umls-concept:C0008972 | lld:lifeskim |
| pubmed-article:16884941 | lifeskim:mentions | umls-concept:C0034603 | lld:lifeskim |
| pubmed-article:16884941 | lifeskim:mentions | umls-concept:C0006098 | lld:lifeskim |
| pubmed-article:16884941 | lifeskim:mentions | umls-concept:C0034107 | lld:lifeskim |
| pubmed-article:16884941 | lifeskim:mentions | umls-concept:C1704922 | lld:lifeskim |
| pubmed-article:16884941 | lifeskim:mentions | umls-concept:C1512044 | lld:lifeskim |
| pubmed-article:16884941 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:16884941 | lifeskim:mentions | umls-concept:C0683887 | lld:lifeskim |
| pubmed-article:16884941 | lifeskim:mentions | umls-concept:C1704788 | lld:lifeskim |
| pubmed-article:16884941 | pubmed:issue | 6-7 | lld:pubmed |
| pubmed-article:16884941 | pubmed:dateCreated | 2006-11-3 | lld:pubmed |
| pubmed-article:16884941 | pubmed:abstractText | Brachytherapy plays a fundamental role in the therapeutic approach of patients with stage I-IV cervical carcinoma. Technical modalities have evolved during the last decades: stepping source technology, imaging modalities development, specially IMN, treatment planning system integrating 3D images. Images from CT-Scan and MRI have contributed to a better knowledge of tumoral extension and critical organs. CT and/or MRI compatible applicators allow a sectional image based approach with a better definition of tumour volume compared to traditional approaches. The introduction of 3D image based approach for GTV and CTV requires new definitions and a common language. In 2000, a working group within GEC-ESTRO was created to support 3D image based 3D treatment planning approach in cervix cancer BT. The task was to determine a common terminology enabling various groups to use a common language. Recommendations were described and proposed based on clinical experience and dosimetric concepts of different institutions. Two CTVs were described en relation to the risk for recurrence: high-risk CTV and intermediate risk CTV. In order to better define the role of such definitions and their potential impact on the complication incidence in patients with cervical cancer, a special French programme was developed. The aim of this programme is to study the incidence of the severe 2-year complication rate in two comparable patient populations: one population is treated using PDR brachytherapy with CT-Scan or MRI with the applicators in place allowing a 3D dosimetry with optimization, the second population is treated using standard X-rays radiographs without any delineation of the target nor optimisation. Each population arm includes 425 patients. A medicoeconomic assessment is performed, allowing a real cost of the most sophisticated approach compared to a historical dosimetric system. | lld:pubmed |
| pubmed-article:16884941 | pubmed:language | fre | lld:pubmed |
| pubmed-article:16884941 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16884941 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16884941 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16884941 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16884941 | pubmed:issn | 1278-3218 | lld:pubmed |
| pubmed-article:16884941 | pubmed:author | pubmed-author:Haie-MederCC | lld:pubmed |
| pubmed-article:16884941 | pubmed:author | pubmed-author:PeiffertDD | lld:pubmed |
| pubmed-article:16884941 | pubmed:issnType | lld:pubmed | |
| pubmed-article:16884941 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:16884941 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16884941 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16884941 | pubmed:pagination | 402-9 | lld:pubmed |
| pubmed-article:16884941 | pubmed:meshHeading | pubmed-meshheading:16884941... | lld:pubmed |
| pubmed-article:16884941 | pubmed:meshHeading | pubmed-meshheading:16884941... | lld:pubmed |
| pubmed-article:16884941 | pubmed:meshHeading | pubmed-meshheading:16884941... | lld:pubmed |
| pubmed-article:16884941 | pubmed:meshHeading | pubmed-meshheading:16884941... | lld:pubmed |
| pubmed-article:16884941 | pubmed:meshHeading | pubmed-meshheading:16884941... | lld:pubmed |
| pubmed-article:16884941 | pubmed:meshHeading | pubmed-meshheading:16884941... | lld:pubmed |
| pubmed-article:16884941 | pubmed:meshHeading | pubmed-meshheading:16884941... | lld:pubmed |
| pubmed-article:16884941 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16884941 | pubmed:articleTitle | [Innovation in gynaecological brachytherapy: new technologies, pulse dose-rate brachytherapy, image, definition of new volumes of interest and their impact on dosimetry: application in a clinical research programme "STIC"]. | lld:pubmed |
| pubmed-article:16884941 | pubmed:affiliation | Service de Curiethérapie, Institut Gustave-Roussy, 39, Rue Camille-Desmoulins, 94805 Villejuif, France. haie@igr.fr | lld:pubmed |
| pubmed-article:16884941 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16884941 | pubmed:publicationType | English Abstract | lld:pubmed |